DiaMedica Therapeutics Inc. (DMAC) Free cash flow 2017–2025
DiaMedica Therapeutics Inc. (DMAC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.1MFY2025 · since FY2017: -$3.9M → -$29.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.1M | -31.7% |
| FY2024 | -$22.1M | -17.9% |
| FY2023 | -$18.8M | -61.8% |
| FY2022 | -$11.6M | +5.6% |
| FY2021 | -$12.3M | -33.0% |
| FY2020 | -$9.2M | -1.4% |
| FY2019 | -$9.1M | -58.4% |
| FY2018 | -$5.7M | -46.5% |
| FY2017 | -$3.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice